associ
system
inflammatori
respons
syndrom
sir
antiinflammatori
respons
syndrom
commonli
manifest
patient
trauma
burn
injuri
major
surgeri
patient
increasingli
suscept
infect
variou
pathogen
due
excess
releas
antiinflammatori
cytokin
antiinflammatori
effector
cell
recent
ccchemokin
ligand
found
sera
mice
pancreat
identifi
activ
molecul
sirsassoci
antiinflammatori
respons
manifest
also
inhibitori
activ
glycyrrhizin
gl
product
report
therefor
effect
gl
sirsassoci
antiinflammatori
respons
manifest
investig
murin
sir
model
without
stimul
splenic
cell
mice
day
sir
induct
produc
cytokin
associ
antiinflammatori
respons
manifest
howev
cytokin
produc
splenic
cell
sir
mice
previous
treat
gl
dualchamb
transwel
cell
gener
normal
cell
cultur
peripher
blood
polymorphonuclear
neutrophil
pmn
sir
mice
howev
cell
gener
normal
cell
transwel
cultur
perform
pmn
gltreat
sir
mice
produc
pmn
sir
mice
chemokin
demonstr
cultur
pmn
sir
mice
treat
gl
result
indic
gl
capac
suppress
sirsassoci
antiinflammatori
respons
manifest
inhibit
product
pmn
glycyrrhizin
inhibit
manifest
antiinflammatori
respons
appear
associ
system
inflammatori
respons
syndrom
sir
like
reaction
system
inflammatori
respons
syndrom
sir
frequent
develop
patient
polytrauma
sever
burn
injuri
major
surgeri
sir
system
inflammatori
reaction
develop
local
inflammatori
respons
injur
tissu
local
infect
infect
demonstr
patient
sir
classifi
sepsi
sever
sir
accompani
multipl
organ
dysfunct
syndrom
mod
ultim
lead
multipl
organ
failur
mof
result
death
therefor
clinic
cours
patient
polytrauma
sever
burn
injuri
major
surgeri
appear
strongli
associ
manifest
sir
overwhelm
system
proinflammatori
reaction
caus
sir
lead
overact
antiinflammatori
respons
antiinflammatori
respons
appear
regul
inflammatori
respons
sir
antiinflammatori
respons
appear
associ
sir
defin
impair
hladr
express
less
compar
healthi
control
increas
plasma
concentr
cytokin
suscept
patient
sirsassoci
antiinflammatori
respons
infect
increas
greatli
due
cytokineassoci
immunosuppress
previous
demonstr
sir
decreas
host
antibacteri
resist
mice
sever
pancreat
murin
model
repres
sir
suscept
sepsi
induc
cecal
ligat
punctur
clp
addit
cc
chemokin
ligand
circul
shown
contribut
increas
suscept
mice
clpinduc
sepsi
glycyrrhizin
gl
extract
licoric
root
structur
acid
describ
inhibit
inflamm
augment
natur
killer
cell
activ
induc
ifnc
product
japan
gl
use
clinic
year
patient
chronic
hepat
gl
antivir
activ
human
cytomegaloviru
herp
simplex
viru
type
influenza
viru
hiv
coronaviru
recent
gl
describ
inhibitor
product
cultur
human
monocyt
infect
mtropic
hiv
therefor
studi
regulatori
effect
gl
sirsassoci
antiinflammatori
respons
manifest
investig
mous
model
sir
studi
chose
use
term
sir
sirslik
syndrom
mice
although
strict
definit
sir
appli
human
appli
anim
result
show
gl
downregul
sirsassoci
antiinflammatori
respons
manifest
inhibit
product
polymorphonuclear
neutrophil
pmn
eightto
nineweekold
balbc
mice
jackson
laboratori
bar
harbor
use
experi
experiment
protocol
anim
studi
approv
institut
anim
care
use
committe
univers
texa
medic
branch
galveston
iacuc
approv
number
monoclon
antibodi
mab
tnfa
purchas
bd
pharmingen
san
diego
ca
recombin
murin
tnfa
obtain
peprotech
rocki
hill
nj
cell
prepar
spleen
normal
sir
mice
use
cell
enrich
column
r
system
previous
describ
puriti
cell
greater
describ
previous
previous
describ
pmn
isol
whole
peripher
blood
use
ficollhypaqu
dextran
sediment
briefli
peripher
blood
withdrawn
heart
mice
heparin
syring
peripher
blood
centrifug
ficollhypaqu
precipit
obtain
pmn
rich
fraction
precipit
suspend
dextran
pharmacia
piscataway
nj
kept
h
room
temperatur
allow
sediment
residu
erythrocyt
result
pmn
fraction
treat
erythrocytelys
kit
r
system
elimin
small
amount
erythrocyt
puriti
pmn
obtain
routin
analyz
flow
cytometri
fitcconjug
mab
writegiemsaalp
stain
monocyt
contain
pmn
prepar
analyz
use
peconjug
mab
specif
mous
macrophagesmonocyt
facscan
flow
cytomet
cultiv
variou
cell
prepar
resuspend
medium
supplement
heatinactiv
fetal
bovin
serum
fb
mm
lglutamin
antibiot
uml
penicillin
lgml
streptomycin
cultur
medium
gl
suppli
minophagen
pharmaceut
co
ltd
tokyo
japan
vivo
experi
gl
dissolv
salin
appropri
concentr
ml
solut
administ
ip
g
mice
h
sir
induct
vitro
experi
gl
dissolv
cultur
medium
appropri
concentr
solut
ad
cultur
pmn
report
mani
paper
noncytotox
properti
gl
dose
lgml
report
paper
cytotox
effect
gl
test
variou
murin
human
cell
trypan
blue
dyeexclus
test
b
prolif
respons
cell
stimul
mab
con
c
class
ii
antigen
express
interferon
product
result
indic
gl
concentr
lgml
cytotox
pmn
mice
pancreat
use
model
repres
sir
pancreat
produc
mice
accord
previous
report
protocol
induc
sir
mice
treat
cerulein
lgkg
ip
hourli
h
combin
lp
mgkg
ip
h
first
inject
cerulein
mice
aliv
day
sir
induct
markedli
enhanc
damag
edema
inflammatori
cell
infiltr
hemorrhag
necrosi
demonstr
histolog
pancrea
mice
indic
multipl
organ
dysfunct
amylas
gpt
got
found
sera
mice
also
decreas
bodi
temperatur
wbc
count
mm
manifest
antiinflammatori
respons
sir
mice
evalu
appear
sera
test
mice
addit
antiinflammatori
respons
manifest
evalu
appear
cell
abil
produc
cytokin
shown
repres
cytokin
antiinflammatori
respons
appear
associ
sir
determin
effect
gl
pmnassoci
gener
antiinflammatori
effector
cell
pmn
sir
mice
treat
without
gl
mgkg
cultur
splenic
cell
normal
mice
dualchamb
transwel
thu
normal
cell
suspens
cellswel
place
lower
chamber
transwel
lm
micropor
costar
corn
ny
cell
ad
lower
chamber
transwel
coat
mixtur
mab
lgml
mab
lgml
one
hundr
microlit
cell
suspens
pmn
cellswel
place
upper
chamber
transwel
twelv
hour
later
upper
chamber
remov
cell
lower
chamber
recultur
day
presenc
ngml
cell
harvest
examin
abil
produc
serum
specimen
mice
variou
hour
sir
induct
assay
tnfa
use
elisa
product
pmn
cellsml
mice
h
sir
induct
cultur
presenc
absenc
gl
rang
lgml
h
induct
splenic
cell
cellsml
mice
day
sir
induct
cultur
h
without
stimul
cultur
fluid
harvest
assay
use
elisa
detect
limit
cytokin
chemokin
pgml
elisa
system
assay
perform
three
time
data
present
mean
sd
comparison
experiment
control
group
made
analysi
varianc
anova
follow
fisher
protect
least
signific
differ
test
result
consid
statist
signific
p
previou
studi
normal
cell
convert
cell
cell
abil
produc
antiinflammatori
responserel
cytokin
dualchamb
transwel
cultiv
pmn
mice
h
sir
induct
indic
solubl
factor
produc
pmn
mice
earli
sir
induct
stimul
subsequ
develop
antiinflammatori
respons
therefor
influenc
gl
appear
solubl
factor
sirsrel
cytokin
tnfa
antiinflammatori
responserel
cytokin
sir
mice
examin
gl
mgkg
administ
ip
mice
h
sir
induct
serum
specimen
prepar
sera
mice
variou
time
sir
induct
amount
tnfa
sera
determin
use
elisa
three
hour
sir
induct
tnfa
concentr
ngml
concentr
ngml
detect
sera
similar
amount
cytokin
detect
sera
mice
treat
gl
sir
induct
fig
subsequ
cytokin
declin
undetect
level
sera
group
within
h
sir
induct
indic
gl
influenc
product
sirsrel
cytokin
sir
mice
hand
first
detect
sera
mice
day
sir
induct
product
reach
peak
day
sir
induct
gradual
declin
howev
detect
sera
mice
treat
gl
sir
induct
fig
addit
product
vitro
splenic
cell
sir
mice
treat
gl
demonstr
splenic
cell
normal
mice
produc
mice
day
fig
effect
gl
product
tnfa
sera
mice
variou
time
sir
induct
mice
treat
gl
mgkg
p
open
symbol
salin
mlmous
ip
fill
symbol
h
sir
induct
serum
specimen
mice
h
day
sir
induct
assay
tnfa
circl
triangl
squar
use
elisa
sir
induct
produc
cytokin
cultur
fluid
time
cell
taken
sir
mice
treat
gl
mgkg
produc
cultur
fluid
fig
result
indic
gl
inhibit
sirsassoci
antiinflammatori
respons
manifest
sir
mice
regulatori
mechan
gl
manifest
antiinflammatori
respons
appear
associ
sir
examin
vitro
use
dualchamb
transwel
splenic
cell
lower
chamber
normal
mice
cultur
pmn
upper
chamber
sir
mice
transwel
accord
result
shown
fig
pmn
obtain
mice
h
sir
induct
result
shown
fig
normal
cell
cultur
pmn
normal
mice
convert
cell
normal
cell
cultur
pmn
sir
mice
acquir
abil
produc
time
cell
demonstr
transwel
cultur
normal
cell
pmn
sir
mice
treat
gl
sinc
found
serum
specimen
sir
mice
identifi
activ
molecul
sirsassoci
antiinflammatori
respons
develop
next
examin
product
cultur
pmn
sir
mice
treat
without
gl
pmn
sir
mice
produc
cultur
fluid
cell
prepar
normal
mice
fig
product
demonstr
cultur
fluid
pmn
sir
mice
treat
gl
result
indic
gl
inhibit
sirsassoci
antiinflammatori
respons
manifest
suppress
product
inhibitori
effect
gl
product
pmn
sir
mice
examin
vitro
pmn
mice
h
sir
induct
treat
variou
dose
gl
h
amount
cultur
fluid
cell
determin
obtain
result
shown
fig
pmn
sir
mice
treat
gl
dose
lgml
product
inhibit
gl
treatment
complet
inhibit
product
lgml
gl
ad
pmn
cultur
result
suggest
gl
capabl
inhibit
product
pmn
sir
mice
inhibit
product
gl
may
potenti
improv
antiinflammatori
respons
manifest
ill
patient
sir
fig
inhibitori
effect
gl
product
splenic
cell
sir
mice
mice
treat
gl
mgkg
ip
h
sir
induct
splenic
cell
cellsml
normal
mice
sir
mice
mice
day
sir
induct
treat
without
gl
cultur
h
without
stimul
cultur
fluid
harvest
assay
open
bar
fill
bar
use
elisa
result
display
mean
sd
n
p
compar
sir
mice
treat
salin
fig
product
normal
cell
dualchamb
transwel
cultur
pmn
sir
mice
previous
treat
gl
sir
mice
treat
without
gl
mgkg
ip
h
sir
induct
normal
cell
cellswel
lower
chamber
pmn
cell
well
upper
chamber
sir
mice
cultur
h
dualchamb
transwel
supplement
mab
lgml
cell
lower
chamber
recultur
day
cell
harvest
examin
abil
produc
p
compar
untreat
sir
mice
fig
product
pmn
sir
mice
treat
without
gl
mice
treat
without
gl
mgkg
ip
h
sir
induct
pmn
cellswel
normal
mice
mice
cultur
h
cultur
fluid
harvest
assay
p
compar
untreat
sir
mice
regulatori
mechan
sir
antiinflammatori
respons
usual
appear
respons
sir
develop
howev
import
host
defens
infect
depress
antiinflammatori
respons
excess
product
therefor
sever
infect
frequent
observ
individu
antiinflammatori
respons
previou
studi
show
antiinflammatori
respons
manifest
sir
mice
respons
produc
pmn
sir
mice
recent
demonstr
gl
abil
inhibit
product
human
peripher
blood
monocyt
infect
hiv
studi
effect
gl
sirsassoci
antiinflammatori
respons
manifest
investig
murin
sir
model
antiinflammatori
effector
cell
splenic
cell
acquir
abil
produc
gener
mice
day
sir
induct
time
ifnc
product
cell
demonstr
product
cell
sir
mice
reduc
treatment
gl
howev
product
ifnc
cell
sir
mice
influenc
treatment
gl
data
shown
dualchamb
transwel
cell
nonsir
mice
normal
cell
convert
cell
cultiv
pmn
sir
mice
howev
normal
cell
convert
cell
transwel
cultur
perform
pmn
sir
mice
treat
gl
similarli
cell
normal
mice
lower
chamber
cultur
normal
mous
pmn
upper
chamber
produc
cultur
fluid
normal
cell
cultur
sir
mous
pmn
acquir
abil
produc
howev
produc
normal
cell
cultur
pmn
gltreat
sir
mice
also
ifnc
detect
cultur
fluid
transwellcultur
cell
normal
mice
lower
chamber
sir
mous
pmn
upper
chamber
pmn
sir
mice
produc
cell
prepar
gltreat
sir
mice
result
indic
gl
abil
suppress
sirsassoci
antiinflammatori
respons
manifest
sir
mice
inhibit
product
pmn
furthermor
examin
product
tnfa
cultur
pmn
isol
sir
mice
previous
treat
gl
mgkg
pmn
prepar
normal
mice
produc
cultur
fluid
pmn
sir
mice
treat
without
gl
produc
also
product
tnfa
pmn
sir
mice
influenc
gl
treatment
data
shown
recent
examin
effect
gl
product
cell
stimul
splenic
cell
cellsml
previous
stimul
ngml
cultur
without
gl
lgml
h
cultur
fluid
harvest
assay
elisa
result
cell
stimul
produc
pgml
cultur
fluid
similarli
produc
cell
cultiv
gl
result
suggest
although
gl
abil
inhibit
product
pmn
product
cell
stimul
influenc
compound
typic
anim
model
human
sir
mice
acut
pancreat
util
studi
typic
sir
indic
multipl
organ
failur
amylas
gpt
got
inflamm
tnfa
found
sera
mice
pancreat
mice
also
decreas
bodi
temperatur
white
blood
cell
count
sir
mice
treat
gl
mgkg
ip
h
sir
induct
sir
indic
unchang
suggest
inhibit
antiinflammatori
respons
manifest
gl
result
antiinflammatori
effect
compound
result
show
gl
inhibit
product
mice
sir
previous
report
antihiv
activ
gl
mediat
part
inhibit
product
hiv
infect
howev
precis
molecular
mechan
inhibitori
effect
remain
unclear
sever
studi
indic
enhanc
region
gene
inhibit
glucocorticoid
progesteron
estrogen
enhanc
region
part
nuclear
factorjb
nfjb
report
suggest
inhibit
gene
express
hormon
might
mediat
inhibit
nfjb
bind
gene
sinc
gl
conjug
molecul
glycyrrhetin
acid
steroid
like
structur
two
molecul
glucuron
acid
gl
may
inhibit
nfjb
bind
gene
influenc
hormon
receptor
studi
requir
clarifi
molecular
mechan
inhibit
product
gl
recent
numer
paper
describ
abil
macrophag
display
wide
varieti
phenotyp
depend
cytokin
environ
inflammatori
process
first
popul
recruit
follow
activ
engag
tolllik
receptor
bind
ifn
receptor
classic
activ
display
strong
potenti
erad
infect
staphylococcu
aureu
mycobacterium
avium
complex
salmonella
typhimurium
trypanosoma
cruzi
lymphocyt
choriomening
viru
influenza
viru
addit
classic
activ
character
major
effector
cell
host
resist
clpinduc
infect
indic
classic
activ
induct
key
control
infect
hand
becom
recogn
activ
altern
pathway
involv
altern
activ
implic
perform
variou
immunosuppress
role
sinc
abl
suppress
transcript
activ
ifncand
lpsrespons
gene
classic
activ
gener
circumst
altern
activ
predomin
may
explain
patient
antiinflammatori
respons
appear
associ
sir
suscept
variou
opportunist
infect
recent
demonstr
sir
mice
predomin
altern
activ
detect
sera
sir
mice
normal
mice
freshli
isol
normal
mice
resid
cultur
sir
mous
sera
recombin
produc
typic
paramet
altern
activ
cultur
fluid
howev
produc
mice
inject
sir
mous
sera
mab
combin
result
indic
host
antibacteri
resist
impair
altern
activ
gener
resid
stimul
sirsassoci
product
paper
demonstr
gl
inhibit
antiinflammatori
respons
manifest
inhibit
product
gl
may
potenti
inhibit
antiinflammatori
responseassoci
opportunist
infect
critic
ill
patient
sever
sir
